Artera AI is a leading precision medicine company that develops artificial intelligence (AI) testing to customize treatments for cancer patients. The company’s tests prognosticate patient outcomes and predict optimal therapy. They offer the first-ever predictive test for localized prostate cancer.
Artera AI’s mission is to improve patient outcomes by providing personalized clinical care. They use AI to develop specialized tools that support precision medicine and help doctors make more informed decisions about cancer treatment. Their tests predict therapeutic benefits and provide risk stratification, which can help doctors choose the best treatment options for their patients.